Global Bone Cancer Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: G4E926AB798CEN
QYResearch

Abstracts

This report focuses on the global Bone Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bone Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Amgen
• Baxter
• Bayer
• Hikma Pharmaceuticals
• Johnson?Johnson
• Recordati Group
• Novartis AG
• ??Pfizer
• Takeda Pharmaceutical

Market segment by Type, the product can be split into

• Chemotherapy
• Targeted Therapy

Market segment by Application, split into

• Primary Bone Cancer
• Secondary Bone Cancer

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Bone Cancer status, future forecast, growth opportunity, key market and key players.
• To present the Bone Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Bone Cancer are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bone Cancer Revenue
1.4 Market Analysis by Type
  1.4.1 Global Bone Cancer Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chemotherapy
  1.4.3 Targeted Therapy
1.5 Market by Application
  1.5.1 Global Bone Cancer Market Share by Application: 2020 VS 2026
  1.5.2 Primary Bone Cancer
  1.5.3 Secondary Bone Cancer
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Bone Cancer Market Perspective (2015-2026)
2.2 Bone Cancer Growth Trends by Regions
  2.2.1 Bone Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Bone Cancer Historic Market Share by Regions (2015-2020)
  2.2.3 Bone Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Bone Cancer Market Growth Strategy
  2.3.6 Primary Interviews with Key Bone Cancer Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Bone Cancer Players by Market Size
  3.1.1 Global Top Bone Cancer Players by Revenue (2015-2020)
  3.1.2 Global Bone Cancer Revenue Market Share by Players (2015-2020)
  3.1.3 Global Bone Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bone Cancer Market Concentration Ratio
  3.2.1 Global Bone Cancer Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Bone Cancer Revenue in 2019
3.3 Bone Cancer Key Players Head office and Area Served
3.4 Key Players Bone Cancer Product Solution and Service
3.5 Date of Enter into Bone Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Bone Cancer Historic Market Size by Type (2015-2020)
4.2 Global Bone Cancer Forecasted Market Size by Type (2021-2026)

5 BONE CANCER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Bone Cancer Market Size by Application (2015-2020)
5.2 Global Bone Cancer Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Bone Cancer Market Size (2015-2020)
6.2 Bone Cancer Key Players in North America (2019-2020)
6.3 North America Bone Cancer Market Size by Type (2015-2020)
6.4 North America Bone Cancer Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Bone Cancer Market Size (2015-2020)
7.2 Bone Cancer Key Players in Europe (2019-2020)
7.3 Europe Bone Cancer Market Size by Type (2015-2020)
7.4 Europe Bone Cancer Market Size by Application (2015-2020)

8 CHINA

8.1 China Bone Cancer Market Size (2015-2020)
8.2 Bone Cancer Key Players in China (2019-2020)
8.3 China Bone Cancer Market Size by Type (2015-2020)
8.4 China Bone Cancer Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Bone Cancer Market Size (2015-2020)
9.2 Bone Cancer Key Players in Japan (2019-2020)
9.3 Japan Bone Cancer Market Size by Type (2015-2020)
9.4 Japan Bone Cancer Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Bone Cancer Market Size (2015-2020)
10.2 Bone Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bone Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Bone Cancer Market Size by Application (2015-2020)

11 INDIA

11.1 India Bone Cancer Market Size (2015-2020)
11.2 Bone Cancer Key Players in India (2019-2020)
11.3 India Bone Cancer Market Size by Type (2015-2020)
11.4 India Bone Cancer Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Bone Cancer Market Size (2015-2020)
12.2 Bone Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Bone Cancer Market Size by Type (2015-2020)
12.4 Central & South America Bone Cancer Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amgen
  13.1.1 Amgen Company Details
  13.1.2 Amgen Business Overview and Its Total Revenue
  13.1.3 Amgen Bone Cancer Introduction
  13.1.4 Amgen Revenue in Bone Cancer Business (2015-2020))
  13.1.5 Amgen Recent Development
13.2 Baxter
  13.2.1 Baxter Company Details
  13.2.2 Baxter Business Overview and Its Total Revenue
  13.2.3 Baxter Bone Cancer Introduction
  13.2.4 Baxter Revenue in Bone Cancer Business (2015-2020)
  13.2.5 Baxter Recent Development
13.3 Bayer
  13.3.1 Bayer Company Details
  13.3.2 Bayer Business Overview and Its Total Revenue
  13.3.3 Bayer Bone Cancer Introduction
  13.3.4 Bayer Revenue in Bone Cancer Business (2015-2020)
  13.3.5 Bayer Recent Development
13.4 Hikma Pharmaceuticals
  13.4.1 Hikma Pharmaceuticals Company Details
  13.4.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Hikma Pharmaceuticals Bone Cancer Introduction
  13.4.4 Hikma Pharmaceuticals Revenue in Bone Cancer Business (2015-2020)
  13.4.5 Hikma Pharmaceuticals Recent Development
13.5 Johnson?Johnson
  13.5.1 Johnson?Johnson Company Details
  13.5.2 Johnson?Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson?Johnson Bone Cancer Introduction
  13.5.4 Johnson?Johnson Revenue in Bone Cancer Business (2015-2020)
  13.5.5 Johnson?Johnson Recent Development
13.6 Recordati Group
  13.6.1 Recordati Group Company Details
  13.6.2 Recordati Group Business Overview and Its Total Revenue
  13.6.3 Recordati Group Bone Cancer Introduction
  13.6.4 Recordati Group Revenue in Bone Cancer Business (2015-2020)
  13.6.5 Recordati Group Recent Development
13.7 Novartis AG
  13.7.1 Novartis AG Company Details
  13.7.2 Novartis AG Business Overview and Its Total Revenue
  13.7.3 Novartis AG Bone Cancer Introduction
  13.7.4 Novartis AG Revenue in Bone Cancer Business (2015-2020)
  13.7.5 Novartis AG Recent Development
13.8 ??Pfizer
  13.8.1 ??Pfizer Company Details
  13.8.2 ??Pfizer Business Overview and Its Total Revenue
  13.8.3 ??Pfizer Bone Cancer Introduction
  13.8.4 ??Pfizer Revenue in Bone Cancer Business (2015-2020)
  13.8.5 ??Pfizer Recent Development
13.9 Takeda Pharmaceutical
  13.9.1 Takeda Pharmaceutical Company Details
  13.9.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.9.3 Takeda Pharmaceutical Bone Cancer Introduction
  13.9.4 Takeda Pharmaceutical Revenue in Bone Cancer Business (2015-2020)
  13.9.5 Takeda Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Bone Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Bone Cancer Revenue
Table 3. Ranking of Global Top Bone Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bone Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Targeted Therapy
Table 7. Global Bone Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Bone Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Bone Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Bone Cancer Market Share by Regions (2015-2020)
Table 11. Global Bone Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Bone Cancer Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Bone Cancer Market Growth Strategy
Table 17. Main Points Interviewed from Key Bone Cancer Players
Table 18. Global Bone Cancer Revenue by Players (2015-2020) (Million US$)
Table 19. Global Bone Cancer Market Share by Players (2015-2020)
Table 20. Global Top Bone Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer as of 2019)
Table 21. Global Bone Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bone Cancer Product Solution and Service
Table 24. Date of Enter into Bone Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 27. Global Bone Cancer Market Size Share by Type (2015-2020)
Table 28. Global Bone Cancer Revenue Market Share by Type (2021-2026)
Table 29. Global Bone Cancer Market Size Share by Application (2015-2020)
Table 30. Global Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 31. Global Bone Cancer Market Size Share by Application (2021-2026)
Table 32. North America Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Bone Cancer Market Share (2019-2020)
Table 34. North America Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 35. North America Bone Cancer Market Share by Type (2015-2020)
Table 36. North America Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 37. North America Bone Cancer Market Share by Application (2015-2020)
Table 38. Europe Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Bone Cancer Market Share (2019-2020)
Table 40. Europe Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Bone Cancer Market Share by Type (2015-2020)
Table 42. Europe Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Bone Cancer Market Share by Application (2015-2020)
Table 44. China Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 45. China Key Players Bone Cancer Market Share (2019-2020)
Table 46. China Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 47. China Bone Cancer Market Share by Type (2015-2020)
Table 48. China Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 49. China Bone Cancer Market Share by Application (2015-2020)
Table 50. Japan Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Bone Cancer Market Share (2019-2020)
Table 52. Japan Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Bone Cancer Market Share by Type (2015-2020)
Table 54. Japan Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Bone Cancer Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Bone Cancer Market Share (2019-2020)
Table 58. Southeast Asia Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Bone Cancer Market Share by Type (2015-2020)
Table 60. Southeast Asia Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Bone Cancer Market Share by Application (2015-2020)
Table 62. India Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 63. India Key Players Bone Cancer Market Share (2019-2020)
Table 64. India Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 65. India Bone Cancer Market Share by Type (2015-2020)
Table 66. India Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 67. India Bone Cancer Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Bone Cancer Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Bone Cancer Market Share (2019-2020)
Table 70. Central & South America Bone Cancer Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Bone Cancer Market Share by Type (2015-2020)
Table 72. Central & South America Bone Cancer Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Bone Cancer Market Share by Application (2015-2020)
Table 74. Amgen Company Details
Table 75. Amgen Business Overview
Table 76. Amgen Product
Table 77. Amgen Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 78. Amgen Recent Development
Table 79. Baxter Company Details
Table 80. Baxter Business Overview
Table 81. Baxter Product
Table 82. Baxter Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 83. Baxter Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. Hikma Pharmaceuticals Company Details
Table 90. Hikma Pharmaceuticals Business Overview
Table 91. Hikma Pharmaceuticals Product
Table 92. Hikma Pharmaceuticals Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 93. Hikma Pharmaceuticals Recent Development
Table 94. Johnson?Johnson Company Details
Table 95. Johnson?Johnson Business Overview
Table 96. Johnson?Johnson Product
Table 97. Johnson?Johnson Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 98. Johnson?Johnson Recent Development
Table 99. Recordati Group Company Details
Table 100. Recordati Group Business Overview
Table 101. Recordati Group Product
Table 102. Recordati Group Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 103. Recordati Group Recent Development
Table 104. Novartis AG Company Details
Table 105. Novartis AG Business Overview
Table 106. Novartis AG Product
Table 107. Novartis AG Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 108. Novartis AG Recent Development
Table 109. ??Pfizer Business Overview
Table 110. ??Pfizer Product
Table 111. ??Pfizer Company Details
Table 112. ??Pfizer Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 113. ??Pfizer Recent Development
Table 114. Takeda Pharmaceutical Company Details
Table 115. Takeda Pharmaceutical Business Overview
Table 116. Takeda Pharmaceutical Product
Table 117. Takeda Pharmaceutical Revenue in Bone Cancer Business (2015-2020) (Million US$)
Table 118. Takeda Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Bone Cancer Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Global Bone Cancer Market Share by Application: 2020 VS 2026
Figure 5. Primary Bone Cancer Case Studies
Figure 6. Secondary Bone Cancer Case Studies
Figure 7. Bone Cancer Report Years Considered
Figure 8. Global Bone Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Bone Cancer Market Share by Regions: 2020 VS 2026
Figure 10. Global Bone Cancer Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Bone Cancer Market Share by Players in 2019
Figure 13. Global Top Bone Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Bone Cancer Revenue in 2019
Figure 15. North America Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Bone Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Amgen Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 24. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Baxter Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 26. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bayer Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 28. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Hikma Pharmaceuticals Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 30. Johnson?Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Johnson?Johnson Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 32. Recordati Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Recordati Group Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 34. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis AG Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 36. ??Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. ??Pfizer Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 38. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Takeda Pharmaceutical Revenue Growth Rate in Bone Cancer Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed